Clinical trials
Phase 3 Metabolic Syndrome trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kobe University | 2 |
| Baker Heart Research Institute | 1 |
| Hospital Civil de Guadalajara | 1 |
| Institute Of Cardiology & Internal Diseases, Kazakhstan | 1 |
| Karolinska Institutet | 1 |
| Medical University of Lodz | 1 |
| Olive Lifesciences Pvt Ltd | 1 |
| Russian Academy of Medical Sciences | 1 |
| Sorlandet Hospital HF | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Syndrome | 10 |
| Insulin Resistance | 3 |
| Diabetes Mellitus | 2 |
| Diabetes Mellitus, Lipoatrophic | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Obesity | 2 |
| Anxiety Disorders | 1 |
| Depressive Disorder | 1 |
| Dyslipidemias | 1 |
| Glucose Intolerance | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.